Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period

被引:99
作者
Testa, D
Lovati, R
Ferrarini, M
Salmoiraghi, F
Filippini, G
机构
[1] Ist Nazl Neurol Carlo Besta, Dept Neurol, IT-20133 Milan, Italy
[2] Ist Nazl Neurol Carlo Besta, Dept Neuroepidemiol, IT-20133 Milan, Italy
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2004年 / 5卷 / 04期
关键词
amyotrophic lateral sclerosis; epidemiology; mortality; survival predictors;
D O I
10.1080/14660820410021311
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We reviewed retrospectively 793 consecutive patients discharged with ALS diagnosis between 1971 and 1998 to identify survival predictors. Vital status in July 2001 was known for all patients. Mean age at onset was 56 (SD 11.7) years and mean age at diagnosis was 57.4 (SD 11.5) years. Onset symptoms were bulbar in 20.8% of patients. The median survival time from symptoms onset was 2.9 years (95% CI 2.7-3.1). Survival from onset was 93% after one, 48% after three and 24% after five years. Median survival was shorter in patients with time between onset and diagnosis <12 months than in those diagnosed >3 months; (2.1 years vs. 5.9 years; P<0.001). Patients with onset after age 65 had a 4.2 times greater risk of death than patients less than 40 years. Bulbar onset was associated with 1.4 times greater risk of death than spinal onset. Patients diagnosed after 1990 had longer median survival (3.3 years) than those diagnosed in 1971-1979 (2.4 years) (P<0.001). As expected, age, bulbar onset and short time from onset to diagnosis were independent predictors of survival. We also found a significant increase in survival over time, probably due to improved comprehensive treatment of ALS patients in Italy.
引用
收藏
页码:208 / 212
页数:5
相关论文
共 36 条
[11]   Neurotrophins and neurodegeneration [J].
Dawbarn, D ;
Allen, SJ .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (03) :211-230
[12]   Prognosis in amyotrophic lateral sclerosis - A population-based study [J].
del Aguila, MA ;
Longstreth, WT ;
McGuire, V ;
Koepsell, TD ;
van Belle, G .
NEUROLOGY, 2003, 60 (05) :813-819
[13]   Nutritional status is a prognostic factor for survival in ALS patients [J].
Desport, JC ;
Preux, PM ;
Truong, TC ;
Vallat, JM ;
Sautereau, D ;
Couratier, P .
NEUROLOGY, 1999, 53 (05) :1059-1063
[14]   Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS [J].
Drachman, DB ;
Frank, K ;
Dykes-Hoberg, M ;
Teismann, P ;
Almer, G ;
Przedborski, S ;
Rothstein, JD .
ANNALS OF NEUROLOGY, 2002, 52 (06) :771-778
[15]   DURATION OF AMYOTROPHIC-LATERAL-SCLEROSIS IS AGE-DEPENDENT [J].
EISEN, A ;
SCHULZER, M ;
MACNEIL, M ;
PANT, B ;
MAK, E .
MUSCLE & NERVE, 1993, 16 (01) :27-32
[16]   AMYOTROPHIC LATERAL SCLEROSIS - A STUDY OF ITS PRESENTATION AND PROGNOSIS [J].
GUBBAY, SS ;
KAHANA, E ;
ZILBER, N ;
COOPER, G ;
PINTOV, S ;
LEIBOWITZ, Y .
JOURNAL OF NEUROLOGY, 1985, 232 (05) :295-300
[17]   NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS IN A DATABASE POPULATION - VALIDATION OF A SCORING SYSTEM AND A MODEL FOR SURVIVAL PREDICTION [J].
HAVERKAMP, LJ ;
APPEL, V ;
APPEL, SH .
BRAIN, 1995, 118 :707-719
[18]   Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? [J].
Househam, E ;
Swash, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 180 (1-2) :76-81
[19]   The diagnostic interval in amyotrophic lateral sclerosis [J].
Iwasaki, Y ;
Ikeda, K ;
Ichikawa, Y ;
Igarashi, O ;
Kinoshita, M .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (02) :87-89
[20]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481